Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $6.10 USD
Change Today +0.14 / 2.35%
Volume 45.1K
VSTM On Other Exchanges
As of 10:38 AM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Joanna C. Horobin M.B., Ch.B

Senior Advisor,Verastem, Inc.
AgeTotal Calculated CompensationThis person is connected to 21 board members in 2 different organizations across 7 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Joanna C. Horobin, M.B., Ch.B., has been the Senior Advisor of Verastem, Inc., since July 1, 2015. Dr. Horobin served as Chief Medical Officer at Verastem, Inc. from October 2012 to July 1, 2015. Dr. Horobin served as the President of Syndax Pharmaceuticals, Inc. and served as its Chief Executive Officer until April 2012. Dr. Horobin was an Entrepreneur-in-Residence of MPM Capital. She served as Chief Executive Officer of U3 Pharma GmbH (Alternate Name: U3 Pharma ...

Read Full Background

Corporate Headquarters*

117 Kendrick Street
Needham, Massachusetts 02494

United States

Phone: 781-292-4200
Fax: --

Board Members Memberships*



Unknown/Other Education
The Royal College of Physicians
University of Manchester

Other Affiliations*

Annual Compensation*

Total Annual Compensation$388,923

Stock Options*

All Other Compensation$15,177
Exercisable Options100,000
Exercisable Options Value$121,000
Unexercisable Options200,000
Unexercisable Options Value$121,000
Total Value of Options$242,000
Total Number of Options300,000

Total Compensation*

Total Annual Cash Compensation$540,600
Total Short Term Compensation$388,923
Other Long Term Compensation$15,177
Total Calculated Compensation$1,488,421
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VSTM:US $6.10 USD +0.14


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERASTEM INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at